Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia

GLIA

Volumn 60, Issue 1, 2012, Pages 29-42

  Holley, Monica M ^a   Zhang, Yongqing ^b   Lehrmann, Elin ^b   Wood, William H ^b   Becker, Kevin G ^b   Kielian, Tammy ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

JNK; MAPK; Microglia; PI3K; S. aureus; TLR2; TLR9

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 27; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE BACTERIUM; MICROGLIA; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; COMPUTATIONAL BIOLOGY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GRAM-POSITIVE BACTERIA; INTERLEUKIN-12 SUBUNIT P40; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MICROGLIA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TRANSDUCTION, GENETIC;

EID: 81155130797     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21243     Document Type: Article

References (61)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA, activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738.
2. Aloisi F. 2001. Immune function of microglia. Glia 36: 165-179.
3. Blasius AL, Beutler B. 2010. Intracellular toll-like receptors. Immunity 32: 305-315.
4. Bode KA, Schmitz F, Vargas L, Heeg K, Dalpke AH. 2009. Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction. J Immunol 182: 2176-2184.
5. Butchi NB, Du M, Peterson KE. 2010. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 58: 650-664.
6. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, et al. 2009. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 15: 641-648.
7. Cheadle C, Vawter MP, Freed WJ, Becker KG. 2003. Analysis of microarray data using Z score transformation. J Mol Diagn 5: 73-81.
8. Colton CA. 2009. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4: 399-418.
9. Cooper AM, Khader SA. 2007. IL-12p40: An inherently agonistic cytokine. Trends Immunol 28: 33-38.
10. Echchannaoui H, Frei K, Schnell C, Leib SL, Zimmerli W, Landmann R. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186: 798-806.
11. Esen N, Kielian T. 2007. Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). J Neuroinflammation 4: 10.
12. Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. 2009. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol 10: 958-964.
13. Garg S, Nichols JR, Esen N, Liu S, Phulwani NK, Syed MM, Wood WH, Zhang Y, Becker KG, Aldrich A, et al. 2009. MyD88 expression by CNS-resident cells is pivotal for eliciting protective immunity in brain abscesses. ASN Neuro 5;1:pii: e00007. doi: 10.1042/AN20090004.
14. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH. 1998. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol 16: 495-521.
15. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. 2009. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8: 40-52.
16. Gekara NO, Dietrich N, Lyszkiewicz M, Lienenklaus S, Weiss S. 2009. Signals triggered by a bacterial pore-forming toxin contribute to toll-like receptor redundancy in gram-positive bacterial recognition. J Infect Dis 199: 124-133.
17. Ghilardi N, Kljavin N, Chen Q, Lucas S, Gurney AL, De Sauvage FJ. 2004. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol 172: 2827-2833.
18. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur J Immunol 25: 200-206.
19. Goriely S, Neurath MF, Goldman M. 2008. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8: 81-86.
20. Gran B, Zhang GX, Rostami A. 2004. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit Rev Immunol 24: 111-128.
21. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436.
22. Gurley C, Nichols J, Liu S, Phulwani NK, Esen N, Kielian T. 2008. Microglia and astrocyte activation by toll-like receptor ligands: Modulation by PPAR-γ agonists. PPAR Res 2008: 453120.
23. Heeg K, Dalpke A, Peter M, Zimmermann S. 2008. Structural requirements for uptake and recognition of CpG oligonucleotides. Int J Med Microbiol 298: 33-38.
24. Ivanov II, Zhou L, Littman DR. 2007. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409-417.
25. Jana M, Dasgupta S, Saha RN, Liu X, Pahan K. 2003. Induction of tumor necrosis factor-α (TNF-α) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J Neurochem 86: 519-528.
26. Kang TJ, Chae GT. 2001. Detection of toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31: 53-58.
27. Kang TJ, Lee SB, Chae GT. 2002. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20: 56-62.
28. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nat Immunol 11: 373-384.
29. Kielian T. 2006. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83: 711-730.
30. Kielian T, Esen N, Bearden ED. 2005a. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia 49: 567-576.
31. Kielian T, Haney A, Mayes PM, Garg S, Esen N. 2005b. Toll-like receptor 2 modulates the proinflammatory milieu in Staphylococcus aureus-induced brain abscess. Infect Immun 73: 7428-7435.
32. Kielian T, Mayes P, Kielian M. 2002. Characterization of microglial responses to Staphylococcus aureus: Effects on cytokine, costimulatory molecule, and toll-like receptor expression. J Neuroimmunol 130: 86-99.
33. Kim SY, Volsky DJ. 2005. PAGE: Parametric analysis of gene set enrichment. BMC Bioinformatics 6: 144.
34. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845.
35. Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi AK, Short D, Davis HL. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95: 12631-12636.
36. Lankford CS, Frucht DM. 2003. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73: 49-56.
37. Lefkowitz DL, Lincoln JA, Lefkowitz SS, Bollen A, Moguilevsky N. 1997. Enhancement of macrophage-mediated bactericidal activity by macrophage-mannose receptor-ligand interaction. Immunol Cell Biol 75: 136-141.
38. Liu S, Kielian T. 2009. Microglial activation by Citrobacter koseri is mediated by TLR4- and MyD88-dependent pathways. J Immunol 183: 5537-5547.
39. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183: 147-157.
40. McAleer JP, Kolls JK. 2011. Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 90: 263-270.
41. O'Neill LA, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
42. Okun E, Griffioen KJ, Mattson MP. 2011. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 34: 269-281.
43. Re F, Strominger JL. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699.
44. Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci USA 97: 12705-12710.
45. Santos-Sierra S, Golenbock DT, Henneke P. 2006. Toll-like receptor-dependent discrimination of streptococci. J Endotoxin Res 12: 307-312.
46. Shida K, Kiyoshima-Shibata J, Kaji R, Nagaoka M, Nanno M. 2009. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through toll-like receptor 2-dependent and independent mechanisms. Immunology 128: e858-e869.
47. Sifri CD, Park J, Helm GA, Stemper ME, Shukla SK. 2007. Fatal brain abscess due to community-associated methicillin-resistant Staphylococcus aureus strain USA300. Clin Infect Dis 45: e113-e117.
48. Stenzel W, Soltek S, Sanchez-Ruiz M, Akira S, Miletic H, Schluter D, Deckert M. 2008. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 172: 132-145.
49. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RA, Moore KJ. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170: 477-485.
50. Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF. 2002. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32: 1212-1222.
51. Takeuchi O, Hoshino K, Akira S. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165: 5392-5396.
52. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
53. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
54. Tsai WH, Huang DY, Yu YH, Chen CY, Lin WW. 2011. Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages. Cell Microbiol 13: 717-730.
55. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
56. Vance RE, Isberg RR, Portnoy DA. 2009. Patterns of pathogenesis: Discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6: 10-21.
57. Vidlak D, Mariani MM, Aldrich A, Liu S, Kielian T. 2010. Roles of toll-like receptor 2 (TLR2) and superantigens on adaptive immune responses during CNS staphylococcal infection. Brain Behav Immun 25: 905-914.
58. Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W. 2008. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 118: 545-559.
59. Watanabe T, Kitani A, Murray PJ, Strober W. 2004. NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800-808.
60. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. 2006. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25: 473-485.
61. Zimmer H, Riese S, Regnier-Vigouroux A. 2003. Functional characterization of mannose receptor expressed by immunocompetent mouse microglia. Glia 42: 89-100.